Navigating the regulatory pathway for an innovative bionic vision system

K. Chevrie

doi:10.1117/12.2560182

21 February 2020 Navigating the regulatory pathway for an innovative bionic vision system

K. Chevrie

Proceedings Volume 11229, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVIII; 112290X (2020) https://doi.org/10.1117/12.2560182
Event: SPIE BiOS, 2020, San Francisco, California, United States

Abstract

Bionic vision restoration systems incorporating an implantable device belong to the highest regulatory risk class in the USA and Europe (i.e Class III). As such, their release to the market or their use in clinical trials is subject to authorization by the competent authorities. These authorizations are based on thorough evaluation procedures which impose on the manufacturer the highest level of evidence of compliance with regulatory requirements. In order to obtain these authorizations in the shortest possible time, it is necessary to understand, in detail, the requirements specified in the regulations and their interpretation by the competent authorities. The means of demonstration of conformity and the criteria for acceptance must also be defined to ensure that they meet the expectations of the competent authorities. In the case of breakthrough innovation, these different aspects are even more difficult to determine as there is no predicate or state of the art on which the manufacturer and the competent authorities can rely. It is therefore necessary to deploy a regulatory strategy very early on incorporating as much input as possible from the competent authorities, in order to increase the probability of approval and thus streamline the regulatory pathway. We will present, as an example, the method we developed for the Prima Bionic Vision System and discuss the specificities of medical devices; including incremental development and short development cycles versus regulatory time and how to manage this particularity for breakthrough devices.

Conference Presentation

Citation Download Citation

K. Chevrie "Navigating the regulatory pathway for an innovative bionic vision system", Proc. SPIE 11229, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVIII, 112290X (21 February 2020); https://doi.org/10.1117/12.2560182

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available